Cytokines and Cancer Anorexia Cachexia Syndrome

被引：44

作者：

Bennani-Baiti, Nabila ^{[1
]}

Davis, Mellar P. ^{[1
]}

机构：

[1] Cleveland Clin, Harry R Horvitz Ctr Palliat Med, Taussig Canc Ctr, Cleveland, OH 44195 USA

来源：

AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE | 2008年 / 25卷 / 05期

关键词：

cancer; cytokines; cancer-related cachexia; anorexia; tissue wasting;

D O I：

10.1177/1049909108315518

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

Cancer anorexia cachexia syndrome is frequent yet still a not well understood cancer-related problem. The pathophysiology of cancer cachexia is multifactorial. It is suggested to be the result of tumor-host interactions and studies of the disturbances seen during cancer anorexia cachexia syndrome, such as anorexia, hypermetabolism, tissue wasting, metabolic abnormalities, and hormonal changes, all point to the involvement in one way or another of one key factor: cytokines. The purpose of this review is to summarize the latest developments in the field of cytokines and their role in cancer anorexia cachexia syndrome. The emphasis is on the role of cytokines in anorexia and tissue wasting.

引用

页码：407 / 411

页数：5

共 45 条

[1] Cytokines in the pathogenesis of cancer cachexia [J].

Argilés, JM ;

Busquets, S ;

López-Soriano, FJ .

CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2003, 6 (04) :401-406

[2] ACTIVATION OF THE ATP-UBIQUITIN-PROTEASOME PATHWAY IN SKELETAL-MUSCLE OF CACHECTIC RATS BEARING A HEPATOMA [J].

BARACOS, VE ;

DEVIVO, C ;

HOYLE, DHR ;

GOLDBERG, AL .

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1995, 268 (05) :E996-E1006

[3]

BARACOS VE, 2005, PHARMACOTHERAPY CACH, P101

[4] CHARACTERIZATION OF DIFFERENTIATION FACTOR LEUKEMIA INHIBITORY FACTOR EFFECT ON LIPOPROTEIN-LIPASE ACTIVITY AND MESSENGER-RNA IN 3T3-L1 ADIPOCYTES [J].

BERG, M ;

FRAKER, DL ;

ALEXANDER, HR .

CYTOKINE, 1994, 6 (04) :425-432

[5] Increased muscle ubiquitin mRNA levels in gastric cancer patients [J].

Bossola, M ;

Muscaritoli, M ;

Costelli, P ;

Bellantone, R ;

Pacelli, F ;

Busquets, S ;

Argilès, J ;

Lopez-Soriano, FJ ;

Civello, IM ;

Baccino, FM ;

Fanelli, FR ;

Doglietto, GB .

AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2001, 280 (05) :R1518-R1523

[6] Cytokine-hormone interactions:: Tumor necrosis factor α impairs biologic activity and downstream activation signals of the insulin-like growth factor I receptor in myoblasts [J].

Broussard, SR ;

McCusker, RH ;

Novakofski, JE ;

Strle, K ;

Shen, WH ;

Johnson, RW ;

Freund, GG ;

Dantzer, R ;

Kelley, KW .

ENDOCRINOLOGY, 2003, 144 (07) :2988-2996

[7] Thalidomide in patients with cachexia due to terminal cancer: Preliminary report [J].

Bruera, E ;

Neumann, CM ;

Pituskin, E ;

Calder, K ;

Ball, G ;

Hanson, J .

ANNALS OF ONCOLOGY, 1999, 10 (07) :857-859

[8] PLASMA AND CSF TRYPTOPHAN IN CANCER ANOREXIA [J].

CANGIANO, C ;

CASCINO, A ;

CECI, F ;

LAVIANO, A ;

MULIERI, M ;

MUSCARITOLI, M ;

ROSSIFANELLI, F .

JOURNAL OF NEURAL TRANSMISSION-GENERAL SECTION, 1990, 81 (03) :225-233

[9] Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats [J].

Carbo, N. ;

Lopez-Soriano, J. ;

Costelli, P. ;

Busquets, S. ;

Alvarez, B. ;

Baccino, F. M. ;

Quinn, L. S. ;

Lopez-Soriano, F. J. ;

Argiles, J. M. .

BRITISH JOURNAL OF CANCER, 2000, 83 (04) :526-531

[10] TUMOR-NECROSIS-FACTOR-ALPHA MEDIATES CHANGES IN TISSUE PROTEIN-TURNOVER IN A RAT CANCER CACHEXIA MODEL [J].

COSTELLI, P ;

CARBO, N ;

TESSITORE, L ;

BAGBY, GJ ;

LOPEZSORIANO, FJ ;

ARGILES, JM ;

BACCINO, FM .

JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) :2783-2789

← 1 2 3 4 5 →